Data Analyst 2
Certara
Data Analyst 2
Certara
Biosimulation and model-informed drug development platform
About Certara
Certara accelerates the potential of bringing medicines to market and to patients using biosimulation software, technology, and services to transform traditional drug discovery and development. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
Our goal is to enable the life sciences industry’s use of data, modeling, and analytics to make better decisions across the various phases of discovery and drug development. Our software and scientists incorporate modern advances in scientific understanding, drug development experience, data analysis, and AI resulting in significant opportunities to decrease the cost and increase the probability of success for new drug approval and commercialization.
This job entails interpretation of Clinical trials data across various therapeutic areas and actively contribute to the development of database products that support informed decision making at various stages of clinical development and post approval phases using modelling and simulation approaches. This job necessitates a profound knowledge of pharmacology and clinical research, experience in development/process of clinical databases for conducting systematic literature review and meta-analysis (pair wise, network and model based meta-analysis).
Skills & Abilities:
Certara bases all employment-related decision on merit, taking into consideration qualifications, skills, achievement, and performance. We treat all applicants and employees without regard to personal characteristics such as race, color, ethnicity, religion, sex, sexual orientation, age, nationality, marital status, pregnancy, physical or mental condition, genetic information, military service, or other characteristic protected by law.
Certara provides biosimulation and model-informed drug development tools and services to biopharma, CROs, and researchers. Its platforms include Phoenix WinNonlin for PK/PD and non-compartmental analysis, Simcyp for PBPK modeling, and D360 for scientific informatics, plus Certara.AI for AI-assisted medical writing and regulatory documentation, enabling users to build and run mathematical models that predict drug behavior across development. It differentiates itself with an end-to-end ecosystem, deep regulatory experience, and wide adoption among leading companies and agencies. Its goal is to speed up decision-making, reduce uncertainty, and help deliver safe, effective medicines to patients faster.
Explore more opportunities at Certara